Pesticides & Agrochemicals · Founded 1958 · www.bayer.in / www.cropscience.bayer.com · BSE 506285 · NSE BAYER CROP · ISIN INE462A01022
No Notes Added Yet
Business
Bayer CropScience Ltd. is a leading player in the Indian agricultural sector, operating as a subsidiary of the global life sciences company Bayer AG. The company is primarily engaged in the business of crop protection, seeds, and digital farming solutions. It develops, produces, and markets a wide range of products including herbicides, fungicides, insecticides, and high-quality seeds for various crops. Its core business model revolves around providing integrated agricultural solutions to farmers, helping them improve crop yields, quality, and farm profitability. The company generates revenue through the sale of its crop protection products, hybrid seeds, and related agricultural advisory services.
Revenue Mix
Bayer CropScience Ltd.'s primary business can be broadly categorized into:
Crop Protection: This is the dominant segment and includes the sale of herbicides, insecticides, and fungicides designed to protect crops from weeds, pests, and diseases. This segment typically accounts for the majority of the company's revenue.
Seeds: This segment focuses on the development, production, and sale of high-yielding hybrid seeds for various crops such as corn, rice, cotton, and vegetables.
Environmental Science & Digital Farming: While smaller in comparison, this segment includes solutions for non-agricultural pest control and emerging digital tools for precision agriculture.
Exact revenue contributions for each segment are typically detailed in the company's annual financial reports, but Crop Protection consistently forms the largest share.
Industry
The Indian Pesticides & Agrochemicals industry is diverse, competitive, and heavily influenced by monsoon patterns, agricultural policies, and farmer income. It includes global multinational corporations (MNCs) and a large number of domestic players. Bayer CropScience is positioned as one of the leading players in the premium and innovative segment of the market. Leveraging the global R&D and technological prowess of its parent company, Bayer AG, it focuses on offering advanced, often patented, solutions. It competes with other global giants like Syngenta, BASF, Corteva, as well as strong domestic companies such as UPL, PI Industries, and Rallis India.
MOAT
Global R&D and Innovation: As part of Bayer AG, the company benefits from a massive global R&D pipeline, leading to the introduction of novel and often patented crop protection technologies and advanced seed varieties. This allows it to offer differentiated products.
Brand Recognition & Trust: Bayer is a globally recognized and trusted brand among farmers, built on decades of product efficacy and reliability.
Extensive Distribution Network: A well-established and wide-reaching distribution network across India ensures product availability even in remote agricultural regions.
Comprehensive Portfolio: A broad and diverse portfolio of crop protection products and seeds for various crops and geographies provides a strong market presence.
Growth Drivers
Increasing Food Demand: Growing population and rising incomes in India drive the need for higher agricultural productivity and quality produce.
Adoption of Advanced Technologies: Farmers' increasing awareness and willingness to adopt advanced crop protection solutions and high-yielding seeds to enhance productivity and mitigate risks.
Digital Farming Solutions: The nascent but growing adoption of precision agriculture, data analytics, and digital tools for optimized farm management.
Crop Diversification & Intensification: Changing cropping patterns and the need for specialized solutions for diverse crops.
Government Support: Favorable government policies for agriculture, including irrigation projects, credit facilities, and minimum support prices, can boost farmer purchasing power.
Risks
Monsoon Dependency: Indian agriculture is highly reliant on the monsoon. Erratic or insufficient rainfall can significantly impact crop yields, farmer income, and demand for agrochemicals.
Regulatory Environment: Strict and evolving government regulations regarding product approvals, environmental impact, pricing controls, and bans on certain chemicals pose operational risks.
Commodity Price Volatility: Fluctuations in agricultural commodity prices directly affect farmer profitability and their ability to invest in high-value inputs.
Pest Resistance: Continuous evolution of pest and disease resistance requires constant R&D and product innovation, incurring significant costs.
Counterfeit Products: The market faces challenges from the proliferation of spurious and counterfeit agrochemical products, impacting legitimate sales and farmer trust.
Environmental Scrutiny: Increasing global and local environmental concerns over chemical use in agriculture could lead to stricter norms or product restrictions.
Management & Ownership
Bayer CropScience Ltd. is majority-owned by Bayer AG, a German multinational pharmaceutical and life sciences company. The promoter holding typically exceeds 70%. The company benefits from a professional management team, drawing upon global expertise, research capabilities, and best practices from its parent organization. The management quality is generally perceived as strong, with a focus on sustainable agricultural practices and ethical operations.
Outlook
Bayer CropScience Ltd. is well-positioned in the growing Indian agricultural market, leveraging its strong global parentage, robust R&D capabilities, and extensive product portfolio. The increasing demand for food, need for higher yields, and adoption of modern farming practices present significant growth opportunities. However, the company operates in a highly cyclical industry heavily dependent on monsoon patterns, prone to regulatory shifts, and intense competition from both MNCs and domestic players. Its ability to continuously innovate, navigate regulatory complexities, and effectively manage its supply chain amidst volatile raw material prices will be crucial for sustained performance. The focus on sustainable solutions and digital farming could provide a long-term edge.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 955 | 792 | 1631 | 1738 | 1057 | 1046 | 1915 | 1553 | 1106 | 1101 |
| Other Income | 15 | 29 | 27 | 23 | 32 | 37 | 19 | 14 | 16 | 47 |
| Total Income | 970 | 821 | 1659 | 1761 | 1090 | 1084 | 1933 | 1567 | 1122 | 1147 |
| Total Expenditure | 827 | 695 | 1317 | 1554 | 1037 | 876 | 1566 | 1348 | 989 | 898 |
| Operating Profit | 143 | 126 | 342 | 208 | 52 | 208 | 367 | 219 | 133 | 250 |
| Interest | 3 | 5 | 4 | 3 | 4 | 6 | 5 | 4 | 5 | 6 |
| Depreciation | 15 | 16 | 22 | 14 | 15 | 34 | 27 | 14 | 15 | 38 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 124 | 105 | 316 | 190 | 34 | 168 | 335 | 200 | 113 | 206 |
| Provision for Tax | 31 | 9 | 62 | 54 | -1 | 25 | 57 | 48 | 17 | 44 |
| Profit After Tax | 93 | 96 | 254 | 136 | 34 | 143 | 279 | 153 | 96 | 162 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 93 | 96 | 254 | 136 | 34 | 143 | 279 | 153 | 96 | 162 |
| Adjusted Earnings Per Share | 20.7 | 21.4 | 56.6 | 30.4 | 7.6 | 31.9 | 62.1 | 34 | 21.3 | 36.1 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 3723 | 2769 | 2803 | 2710 | 3167 | 3609 | 4261 | 4734 | 5140 | 5106 | 5473 | 5675 |
| Other Income | 91 | 82 | 72 | 39 | 53 | 67 | 66 | 60 | 73 | 81 | 121 | 96 |
| Total Income | 3814 | 2851 | 2874 | 2749 | 3221 | 3676 | 4327 | 4794 | 5213 | 5187 | 5595 | 5769 |
| Total Expenditure | 3211 | 2335 | 2391 | 2301 | 2687 | 2884 | 3452 | 3929 | 4225 | 4152 | 4785 | 4801 |
| Operating Profit | 603 | 516 | 484 | 448 | 534 | 792 | 876 | 866 | 988 | 1035 | 809 | 969 |
| Interest | 5 | 10 | 7 | 11 | 10 | 14 | 13 | 13 | 22 | 20 | 17 | 20 |
| Depreciation | 25 | 25 | 29 | 33 | 44 | 65 | 74 | 65 | 80 | 74 | 85 | 94 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | -130 | 5 | 59 | 104 | 0 | 0 | 0 |
| Profit Before Tax | 574 | 482 | 448 | 404 | 480 | 583 | 795 | 847 | 990 | 941 | 707 | 854 |
| Provision for Tax | 191 | 167 | 157 | 104 | 143 | 109 | 301 | 202 | 232 | 201 | 139 | 166 |
| Profit After Tax | 383 | 315 | 291 | 300 | 337 | 475 | 493 | 645 | 758 | 741 | 568 | 690 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 383 | 315 | 291 | 300 | 337 | 475 | 493 | 645 | 758 | 741 | 568 | 690 |
| Adjusted Earnings Per Share | 104.6 | 89 | 82.2 | 87.5 | 98.3 | 105.7 | 109.8 | 143.7 | 168.9 | 164.9 | 126.5 | 153.5 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 7% | 5% | 9% | 4% |
| Operating Profit CAGR | -22% | -2% | 0% | 3% |
| PAT CAGR | -23% | -4% | 4% | 4% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -22% | -0% | -4% | 1% |
| ROE Average | 20% | 25% | 24% | 20% |
| ROCE Average | 25% | 33% | 33% | 29% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 2033 | 1839 | 2057 | 1778 | 2239 | 2573 | 2550 | 2524 | 2712 | 2849 | 2850 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 1155 | 1359 | 1539 | 1502 | 1614 | 1590 | 1783 | 2365 | 2792 | 2952 | 3117 |
| Total Current Liabilities | 856 | 538 | 829 | 950 | 1684 | 1765 | 2273 | 2073 | 1995 | 1815 | 2441 |
| Total Liabilities | 4044 | 3737 | 4425 | 4230 | 5537 | 5928 | 6607 | 6962 | 7500 | 7616 | 8408 |
| Fixed Assets | 322 | 290 | 311 | 304 | 409 | 438 | 395 | 441 | 437 | 389 | 445 |
| Other Non-Current Assets | 1175 | 1409 | 1594 | 1562 | 1852 | 1850 | 1965 | 2531 | 2949 | 3104 | 3274 |
| Total Current Assets | 2548 | 2037 | 2520 | 2364 | 3271 | 3640 | 4247 | 3989 | 4114 | 4123 | 4689 |
| Total Assets | 4044 | 3737 | 4425 | 4230 | 5537 | 5928 | 6607 | 6962 | 7500 | 7616 | 8408 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 486 | 1130 | 762 | 838 | 417 | 578 | 1067 | 1205 | 781 | 861 | 1157 |
| Cash Flow from Operating Activities | 200 | 207 | 157 | 121 | 433 | 666 | 687 | 216 | 609 | 952 | 262 |
| Cash Flow from Investing Activities | 485 | 16 | -8 | 38 | -415 | -29 | 7 | 64 | 83 | 0 | 86 |
| Cash Flow from Financing Activities | -42 | -590 | -73 | -581 | -158 | -148 | -556 | -703 | -613 | -656 | -619 |
| Net Cash Inflow / Outflow | 644 | -367 | 76 | -421 | -140 | 489 | 138 | -424 | 79 | 296 | -272 |
| Closing Cash & Cash Equivalent | 1130 | 762 | 838 | 417 | 578 | 1067 | 1205 | 781 | 860 | 1157 | 885 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 104.64 | 89.01 | 82.2 | 87.49 | 98.28 | 105.68 | 109.82 | 143.72 | 168.86 | 164.92 | 126.5 |
| CEPS(Rs) | 111.56 | 95.99 | 90.37 | 97.14 | 111.05 | 120.22 | 126.19 | 158.08 | 186.57 | 181.4 | 145.41 |
| DPS(Rs) | 21 | 17 | 17 | 18 | 18 | 25 | 115 | 150 | 130 | 140 | 125 |
| Book NAV/Share(Rs) | 555.44 | 519.6 | 580.99 | 518.45 | 649.8 | 572.94 | 568 | 562.2 | 604.03 | 634.61 | 634.83 |
| Core EBITDA Margin(%) | 13.13 | 15.02 | 13.98 | 14.88 | 13.7 | 17.66 | 16.75 | 14.78 | 15.51 | 15.54 | 10.95 |
| EBIT Margin(%) | 14.81 | 17.01 | 15.43 | 15.1 | 13.97 | 14.53 | 16.7 | 15.77 | 17.16 | 15.66 | 11.53 |
| Pre Tax Margin(%) | 14.69 | 16.67 | 15.19 | 14.69 | 13.68 | 14.19 | 16.44 | 15.53 | 16.78 | 15.34 | 11.26 |
| PAT Margin (%) | 9.81 | 10.91 | 9.87 | 10.92 | 9.6 | 11.55 | 10.2 | 11.84 | 12.85 | 12.07 | 9.04 |
| Cash Profit Margin (%) | 10.46 | 11.76 | 10.85 | 12.12 | 10.85 | 13.14 | 11.72 | 13.02 | 14.2 | 13.27 | 10.39 |
| ROA(%) | 10.21 | 8.1 | 7.13 | 6.93 | 6.9 | 8.28 | 7.87 | 9.51 | 10.49 | 9.8 | 7.09 |
| ROE(%) | 20.29 | 16.27 | 14.94 | 15.65 | 16.83 | 19.77 | 19.25 | 25.43 | 28.96 | 26.63 | 19.93 |
| ROCE(%) | 30.63 | 25.39 | 23.35 | 21.65 | 24.41 | 24.8 | 31.5 | 33.88 | 38.67 | 34.56 | 25.42 |
| Receivable days | 45.87 | 61.65 | 59.51 | 80.68 | 70.58 | 62.93 | 55.61 | 58.91 | 61.25 | 57.56 | 55.55 |
| Inventory Days | 52.1 | 77.64 | 88.68 | 100.11 | 98.63 | 94.2 | 86.4 | 94.98 | 102.67 | 99.69 | 113.49 |
| Payable days | 42.41 | 60.13 | 57.04 | 67.53 | 107.39 | 112.12 | 102.62 | 118.74 | 114.74 | 97.05 | 95.91 |
| PER(x) | 31.78 | 42.34 | 46.15 | 48.04 | 44.61 | 32.73 | 48.31 | 34.67 | 23.97 | 31.79 | 38.95 |
| Price/Book(x) | 5.99 | 7.25 | 6.53 | 8.11 | 6.75 | 6.04 | 9.34 | 8.86 | 6.7 | 8.26 | 7.76 |
| Dividend Yield(%) | 0.63 | 0.45 | 0.45 | 0.43 | 0.41 | 0.72 | 2.17 | 3.01 | 3.21 | 2.67 | 2.54 |
| EV/Net Sales(x) | 2.97 | 4.54 | 4.49 | 5.17 | 4.56 | 4.01 | 5.31 | 4.56 | 3.37 | 4.38 | 3.88 |
| EV/Core EBITDA(x) | 18.3 | 24.36 | 26.03 | 31.23 | 27.06 | 18.25 | 25.83 | 24.93 | 17.52 | 21.62 | 26.23 |
| Net Sales Growth(%) | 14.73 | -25.63 | 1.22 | -3.31 | 16.88 | 13.96 | 18.06 | 11.1 | 8.56 | -0.65 | 7.19 |
| EBIT Growth(%) | 29.74 | -14.96 | -7.49 | -8.73 | 18.14 | 21.72 | 35.22 | 6.52 | 17.76 | -5.08 | -24.62 |
| PAT Growth(%) | 32.3 | -17.73 | -7.65 | 3.13 | 12.33 | 40.76 | 3.92 | 30.87 | 17.5 | -2.33 | -23.3 |
| EPS Growth(%) | 32.3 | -14.94 | -7.65 | 6.43 | 12.33 | 7.53 | 3.92 | 30.87 | 17.5 | -2.33 | -23.3 |
| Debt/Equity(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio(x) | 2.98 | 3.79 | 3.04 | 2.49 | 1.94 | 2.06 | 1.87 | 1.92 | 2.06 | 2.27 | 1.92 |
| Quick Ratio(x) | 2.32 | 2.55 | 2.11 | 1.71 | 1.26 | 1.52 | 1.29 | 1.19 | 1.16 | 1.42 | 0.95 |
| Interest Cover(x) | 125.67 | 49.16 | 65.91 | 36.73 | 47.15 | 43.25 | 64.06 | 66.64 | 45.4 | 49.03 | 42.61 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 71.43 | 71.43 | 71.43 | 71.43 | 71.43 | 71.43 | 71.43 | 71.43 | 71.43 | 71.43 |
| FII | 3.54 | 3.62 | 3.63 | 3.3 | 3.42 | 3.49 | 3.64 | 3.79 | 3.84 | 3.89 |
| DII | 12.7 | 12.8 | 12.47 | 12.08 | 11.7 | 11.55 | 11.38 | 11.21 | 11.46 | 11.89 |
| Public | 12.33 | 12.15 | 12.47 | 13.19 | 13.44 | 13.53 | 13.55 | 13.57 | 13.27 | 12.79 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 |
| FII | 0.16 | 0.16 | 0.16 | 0.15 | 0.15 | 0.16 | 0.16 | 0.17 | 0.17 | 0.17 |
| DII | 0.57 | 0.58 | 0.56 | 0.54 | 0.53 | 0.52 | 0.51 | 0.5 | 0.52 | 0.53 |
| Public | 0.55 | 0.55 | 0.56 | 0.59 | 0.6 | 0.61 | 0.61 | 0.61 | 0.6 | 0.57 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4.49 | 4.49 | 4.49 | 4.49 | 4.49 | 4.49 | 4.49 | 4.49 | 4.49 | 4.49 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +7% | +5% | +9% | +4% |
| Operating Profit CAGR | -22% | -2% | 0% | +3% |
| PAT CAGR | -23% | -4% | +4% | +4% |
| Share Price CAGR | -22% | 0% | -4% | +1% |
| ROE Average | +20% | +25% | +24% | +20% |
| ROCE Average | +25% | +33% | +33% | +29% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 71.43 | 71.43 | 71.43 | 71.43 | 71.43 | 71.43 | 71.43 | 71.43 | 71.43 | 71.43 |
| FII | 3.54 | 3.62 | 3.63 | 3.3 | 3.42 | 3.49 | 3.64 | 3.79 | 3.84 | 3.89 |
| DII | 12.7 | 12.8 | 12.47 | 12.08 | 11.7 | 11.55 | 11.38 | 11.21 | 11.46 | 11.89 |
| Public | 28.57 | 28.57 | 28.57 | 28.57 | 28.57 | 28.57 | 28.57 | 28.57 | 28.57 | 28.57 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 | 3.21 |
| FII | 0.16 | 0.16 | 0.16 | 0.15 | 0.15 | 0.16 | 0.16 | 0.17 | 0.17 | 0.17 |
| DII | 0.57 | 0.58 | 0.56 | 0.54 | 0.53 | 0.52 | 0.51 | 0.5 | 0.52 | 0.53 |
| Public | 1.28 | 1.28 | 1.28 | 1.28 | 1.28 | 1.28 | 1.28 | 1.28 | 1.28 | 1.28 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4.49 | 4.49 | 4.49 | 4.49 | 4.49 | 4.49 | 4.49 | 4.49 | 4.49 | 4.49 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.